Bendamustine for relapsed/refractory classical Hodgkin lymphoma (all ages)

NHS England has considered the evidence submitted as part of a Preliminary Policy Proposal to establish the Clinical Commissioning Policy Statement and have concluded that there is not enough evidence to make bendamustine available the for this condition at this time.

Source:

NHS England